Equinix Inc (EQIX)vsEUDA Health Holdings Limited (EUDA)
EQIX
Equinix Inc
$1,082.83
-0.57%
REAL ESTATE · Cap: $106.79B
EUDA
EUDA Health Holdings Limited
$14.53
+0.28%
REAL ESTATE · Cap: $20.08M
Smart Verdict
WallStSmart Research — data-driven comparison
Equinix Inc generates 179347% more annual revenue ($9.26B vs $5.16M). EQIX leads profitability with a 14.6% profit margin vs 5.2%. EUDA trades at a lower P/E of 26.6x. EQIX earns a higher WallStSmart Score of 50/100 (C-).
EQIX
Buy50
out of 100
Grade: C-
EUDA
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-38.5%
Fair Value
$626.41
Current Price
$1082.83
$456.42 premium
Intrinsic value data unavailable for EUDA.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Strong operational efficiency at 21.5%
Earnings expanding 22.9% YoY
Revenue surging 60.2% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Elevated debt levels
Weak financial health signals
Expensive relative to growth rate
Premium valuation, high expectations priced in
Moderate valuation
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : EQIX
The strongest argument for EQIX centers on Market Cap, Operating Margin, EPS Growth.
Bull Case : EUDA
The strongest argument for EUDA centers on Revenue Growth, Debt/Equity. Revenue growth of 60.2% demonstrates continued momentum.
Bear Case : EQIX
The primary concerns for EQIX are Debt/Equity, Piotroski F-Score, PEG Ratio. A P/E of 74.6x leaves little room for execution misses. Debt-to-equity of 1.61 is elevated, increasing financial risk.
Bear Case : EUDA
The primary concerns for EUDA are P/E Ratio, EPS Growth, Market Cap.
Key Dynamics to Monitor
EQIX profiles as a value stock while EUDA is a hypergrowth play — different risk/reward profiles.
EQIX carries more volatility with a beta of 1.00 — expect wider price swings.
EUDA is growing revenue faster at 60.2% — sustainability is the question.
EUDA generates stronger free cash flow (-3M), providing more financial flexibility.
Bottom Line
EQIX scores higher overall (50/100 vs 31/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Equinix Inc
REAL ESTATE · REIT - SPECIALTY · USA
Equinix, Inc. is an American multinational company headquartered in Redwood City, California, that specializes in Internet connection and data centers.
Visit Website →EUDA Health Holdings Limited
REAL ESTATE · REAL ESTATE SERVICES · USA
EUDA Health Holdings Limited is a biopharmaceutical innovator dedicated to the discovery, development, and commercialization of transformative therapies addressing rare diseases and unmet medical needs. Leveraging cutting-edge technologies and a robust clinical pipeline, the company focuses on pivotal areas such as supportive care and immune modulation. With a strong commitment to research and development, EUDA is poised to advance healthcare innovation and enhance patient outcomes, while striving to broaden access to essential medical therapies through its promising clinical initiatives.
Visit Website →Compare with Other REIT - SPECIALTY Stocks
Want to dig deeper into these stocks?